Blog: Why won't FOS tackle Capita on Arch cru

Author: Laura Miller
IFAonline | 14 Jun 2011 | 08:00

Categories: Investment

Topics: Arch cru| FSA| FOS

laura-miller

The Financial Ombudsman Service (FOS) has managed to reach several Final Decisions against IFAs over Arch cru, but why is it stalling on investigating the fund's authorised corporate director, Capita?

Approximately £400m was invested in Arch cru funds between 2006 and 2009 by roughly 20,000 investors.

About 2,500 of these investors are backing a claim that Capita failed in its duty to ensure the fund was accurately priced, and that it allowed the fund to make higher risk investments than its low risk label permitted.

These are serious allegations which, to its credit Capita, by offering all of the investors Financial Ombudsman rights, has accepted it will be investigated over.

Except it seems highly likely it won't.

In correspondence from a FOS adjudicator last month, seen by IFAonline, it seems the Ombudsman service is going to seek to use its discretion under FSA Complaints Sourcebook DISP rule 3 to avoid dealing with complaints against Capita.

DISP 3.3.4 states "the Ombudsman may dismiss a complaint without considering its merits if he considers... (17) there are other compelling reasons why it is inappropriate for the complaint to be dealt with under the Financial Ombudsman Service".

FOS gives the "compelling reason" that the FSA, as well as Capita, is already reviewing consumer detriment issues arising from what has happened with the CF Arch cru funds, "including, no doubt, the management of those funds by Capita".

The FSA started its investigation in 2009 and for two years investors have heard absolutely nothing about its progress, or when it might be concluded.

IFAs now fear investors understandably eager to see the return of their funds will try to take their adviser to the FOS as a quicker route to redress.

Each individual case will have its merits. The point is, FOS has decided it can and will investigate claims against individual IFAs, but not multi-million pound company Capita.

In at least one case upheld against an adviser, the FOS questioned the classification of the Arch cru investment as "a low to medium risk", due to the impact of the inherent counterparty risk.

The Ombudsman's reluctance to investigate Capita seems both arbitrary and unfair.

Investors and IFAs have long held this view. But now Members of Parliament are about to wade into the debate.

The FSA and Capita are set to come under fresh scrutiny about Arch cru - as Conservative MP Alun Cairns is about to raise the issue in Parliament.

He represents several constituents caught up in the affair, but told a Sunday newspaper he has received letters from hundreds of other investors after he began looking into the issue.

"It's completely unacceptable, 20,000 investors have waited for two years with no information," Cairns told the newspaper this weekend.

He is expected to say the same thing to the House of Commons.

It is testimony to the failure of financial services' regulatory architecture that investors' hopes are pinned on him raising the matter at all.

More investment news

Recommended reading

Categories

Topics

Comments

There are no comments submitted yet. Do you have an interesting opinion? Then be the first to post a comment

Related articles

Most Read

Audio / Visual

Coffee Lounge

View all the winners here

PPR Structured Product Awards 2011

View all the winners here

This year we have 14 awards designed to mark out the very best products in a highly competitive and innovative market. This includes three new awards for 2011 to reflect the developments in this rapidly growing market: Best Dual/Multi-Index Product, Best Structured (Oeic) Fund and Best Structured Product Provider.

Events

event logo

International Fund & Product Awards 2012

14 Jun 2012 - 14 Jun 2012

London, UK

event logo

British Mortgage Awards 2012

03 Jul 2012 - 03 Jul 2012

London, UK

event logo

Cover Webinars

04 Jul 2012 - 04 Jul 2012

London, UK

Poll

Are you more likely to use a Structured Product for:

In Focus

Viewpoints